S.3187 - Food and Drug Administration Safety and Innovation Act

A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. view all titles (24)

All Bill Titles

  • Short: Food and Drug Administration Safety and Innovation Act as passed house.
  • Short: Biosimilar User Fee Act of 2012 as passed house.
  • Short: Generic Drug User Fee Amendments of 2012 as passed house.
  • Short: Medical Device User Fee Amendments of 2012 as passed house.
  • Short: Prescription Drug User Fee Amendments of 2012 as passed house.
  • Short: Synthetic Drug Abuse Prevention Act of 2012 as passed house.
  • Short: Food and Drug Administration Safety and Innovation Act as passed senate.
  • Short: Biosimilar User Fee Act of 2012 as passed senate.
  • Short: Generic Drug User Fee Amendments of 2012 as passed senate.
  • Short: Medical Device User Fee Amendments of 2012 as passed senate.
  • Short: Prescription Drug User Fee Amendments of 2012 as passed senate.
  • Short: Synthetic Drug Abuse Prevention Act of 2012 as passed senate.
  • Official: A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. as introduced.
  • Short: Food and Drug Administration Safety and Innovation Act as introduced.
  • Short: Biosimilar User Fee Act of 2012 as introduced.
  • Short: Generic Drug User Fee Amendments of 2012 as introduced.
  • Short: Medical Device User Fee Amendments of 2012 as introduced.
  • Short: Prescription Drug User Fee Amendments of 2012 as introduced.
  • Short: Food and Drug Administration Safety and Innovation Act as enacted.
  • Short: Biosimilar User Fee Act of 2012 as enacted.
  • Short: Generic Drug User Fee Amendments of 2012 as enacted.
  • Short: Medical Device User Fee Amendments of 2012 as enacted.
  • Short: Prescription Drug User Fee Amendments of 2012 as enacted.
  • Short: Synthetic Drug Abuse Prevention Act of 2012 as enacted.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

Number Date Offered Status Purpose
 
S.Amdt 2465 Jun 21st Offered Of a perfecting nature. (View on THOMAS)
S.Amdt 2464 Jun 21st Offered Of a perfecting nature. (View on THOMAS)
S.Amdt 2463 Jun 21st Offered To change the enactment date. (View on THOMAS)
S.Amdt 2462 Jun 21st Offered Of a perfecting nature. (View on THOMAS)
S.Amdt 2461 Jun 21st Withdrawn To change the enactment date. (View on THOMAS)
S.Amdt 2152 May 23rd Offered (View on THOMAS)
S.Amdt 2151 May 23rd Offered To amend the Controlled Substances Act to make any substance containing hydrocodone as schedule II drug. (View on THOMAS)
S.Amdt 2150 May 23rd Offered (View on THOMAS)
S.Amdt 2149 May 22nd Offered (View on THOMAS)
S.Amdt 2148 May 22nd Offered (View on THOMAS)

Vote on This Bill

50% Users Support Bill

4 in favor / 4 opposed
 

Send Your Senator a Letter

about this bill Support Oppose Tracking
Track with MyOC

Top-Rated Comments